Nuchal translucency measurement and congenital heart defects: Modest association in low-risk pregnancies

Prenatal Diagnosis

Volumn 27, Issue 2, 2007, Pages 164-169

  Muller M A ^a   Clur, S A ^a   Timmerman, E ^a   Bilardo, C M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cardiac defects; Nuchal translucency; Ultrasound screening

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHROMOSOME; CONGENITAL DEAFNESS; CONTROLLED STUDY; FEMALE; HUMAN; NETHERLANDS; NUCHAL TRANSLUCENCY MEASUREMENT; PERINATAL PERIOD; PREGNANCY; PRENATAL PERIOD; PRIORITY JOURNAL; RISK FACTOR;

ADULT; CONFIDENCE INTERVALS; EPIDEMIOLOGIC METHODS; FEMALE; FETAL DISEASES; HEART DEFECTS, CONGENITAL; HUMANS; MASS SCREENING; NECK; NETHERLANDS; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY OUTCOME; PREVALENCE; RISK FACTORS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, PRENATAL;

EID: 33847157198     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1643     Document Type: Article

References (36)

1. Abu-Harb M, Hey E, Wren C. 1994. Death in infancy from unrecognised congenital heart disease. Arch Dis Child 71(1): 3-7.
2. Arzt W, Tulzer G, Aigner M, Mair R, Hafner E. 2003. Invasive intrauterine treatment of pulmonary atresia/intact ventricular septum with heart failure. Ultrasound Obstet Gynecol 21(2): 186-188.
3. Atzei A, Gajewska K, Huggon IC, Allan L, Nicolaides KH. 2005. Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype. Ultrasound Obstet Gynecol 26(2): 154-157.
4. Bilardo CM, Pajkrt E, de Graaf I, Mol BW, Bleker OP. 1998. Outcome of fetuses with enlarged nuchal translucency and normal karyotype. Ultrasound Obstet Gynecol 11(6): 401-406.
5. Boneva RS, Botto LD, Moore CA, Yang Q, Correa A, Erickson JD. 2001. Mortality associated with congenital heart defects in the United States: trends and racial disparities, 1979-1997. Circulation 103(19): 2376-2381.
6. Bonnet D, Coltri A, Butera G, et al. 1999. Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality. Circulation 99(7): 916-918.
7. Bull C. 1999. Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK. British paediatric cardiac association. Lancet 354(9186): 1242-1247.
8. Buskens E, Grobbee DE, Frohn-Mulder IM, et al. 1996. Efficacy of routine fetal ultrasound screening for congenital heart disease in normal pregnancy. Circulation 94(1): 67-72.
9. Campbell S. 2001. Opinion: isolated major congenital heart disease. Ultrasound Obstet Gynecol 17(5): 370-379.
10. Carvalho JS, Mavrides E, Shinebourne EA, Campbell S, Thilaganathan B. 2002. Improving the effectiveness of routine prenatal screening for major congenital heart defects. Heart 88(4): 387-391.
11. Galindo A, Comas C, Martinez JM, et al. 2003. Cardiac defects in chromosomally normal fetuses with increased nuchal translucency at 10-14 weeks of gestation. J Matern Fetal Neonatal Med 13(3): 163-170.
12. Garne E, Loane M, Dolk H, et al. 2005. Prenatal diagnosis of severe structural congenital malformations in Europe. Ultrasound Obstet Gynecol 25: 6-11.
13. Ghi T, Huggon IC, Zosmer N, Nicolaides KH. 2001. Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype. Ultrasound Obstet Gynecol 18(6): 610-614.
14. Hafner E, Schuller T, Metzenbauer M, Schuchter K, Philipp K. 2003. Increased nuchal translucency and congenital heart defects in a low-risk population. Prenat Diagn 23(12): 985-989.
15. Hoffman JI, Christianson R. 1978. Congenital heart disease in a cohort of 19,502 births with long-term follow-up. Am J Cardiol 42(4): 641-647.
16. Hyett J, Moscoso G, Papapanagiotou G, Perdu M, Nicolaides KH. 1996. Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 7(4): 245-250.
17. Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH. 1999. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study [see comments]. BMJ 318(7176): 81-85.
18. Kidd SA, Lancaster PA, McCredie RM. 1993. The incidence of congenital heart defects in the first year of life. J Paediatr Child Health 29(5): 344-349.
19. Levi S. 2003. Mass screening for fetal malformations: the Eurofetus Study. Ultrasound Obstet Gynecol 22(6): 555-558.
20. Maher JE, Colvin EV, Samdarshi TE, Owen J, Hauth JC. 1994. Fetal echocardiography in gravidas with historic risk factors for congenital heart disease. Am J Perinatol 11(5): 334-336.
21. Makrydimas G, Sotiriadis A, Ioannidis JP. 2003. Screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis. Am J Obstet Gynecol 189(5): 1330-1335.
22. Mavrides E, Cobian-Sanchez F, Tekay A, et al. 2001. Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects. Ultrasound Obstet Gynecol 17(2): 106-110.
23. McAuliffe FM, Hornberger LK, Winsor S, Chitayat D, Chong K, Johnson JA. 2004. Fetal cardiac defects and increased nuchal translucency thickness: a prospective study. Am J Obstet Gynecol 191(4): 1486-1490.
24. Meyer-Wittkopf M, Simpson JM, Sharland GK. 1996. Incidence of congenital heart defects in fetuses of diabetic mothers: a retrospective study of 326 cases. Ultrasound Obstet Gynecol 8(1): 8-10.
25. Mitchell SC, Korones SB, Berendes HW. 1971. Congenital heart disease in 56,109 births. Incidence and natural history. Circulation 43(3): 323-332.
26. Nicolaides KH. Technical guidelines for NT screening: www. fetalmedicine.com.
27. Orvos H, Wayda K, Kozinszky Z, Katona M, Pal A, Szabo J. 2002. Increased nuchal translucency and congenital heart defects in euploid fetuses. The Szeged experience. Eur J Obstet Gynecol Reprod Biol 101(2): 124-128.
28. Rustico MA, Benettoni A, D'Ottavio G, et al. 1995. Fetal heart screening in low-risk pregnancies. Ultrasound Obstet Gynecol 6(5): 313-319.
29. Schwarzler P, Carvalho JS, Senat MV, Masroor T, Campbell S, Ville Y. 1999. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population. Br J Obstet Gynaecol 106(10): 1029-1034.
30. Sharland GK, Allan LD. 1992. Screening for congenital heart disease prenatally. Results of a 2 1/2-year study in the South East Thames Region. Br J Obstet Gynaecol 99(3): 220-225.
31. Souka AP, Krampl E, Bakalis S, Heath V, Nicolaides KH. 2001. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound Obstet Gynecol 18(1): 9-17.
32. Stümpflen I, Stümpflen A, Wimmer M, Bernaschek G. 1996. Effect of detailed fetal echocardiography as part of routine prenatal ultrasonographic screening on detection of congenital heart disease. Lancet 348: 854-857.
33. Tegnander E, Eik-Nes SH, Linker DT. 1994. Incorporating the four-chamber view of the fetal heart into the second-trimester routine fetal examination. Ultrasound Obstet Gynecol 4(1): 24-28.
34. Tegnander E, Williams W, Johansen OJ, Blaas H-GK, Eik-Nes SH. 2006. Prenatal detection of heart defects in a non-selected population of 30149 fetuses-detection rates and outcome. Ultrasound Obstet Gynecol 27: 252-265.
35. Tworetzky W, McElhinney DB, Reddy VM, Brook MM, Hanley FL, Silverman NH. 2001. Improved surgical outcome after fetal diagnosis of hypoplastic left heart syndrome. Circulation 103(9): 1269-1273.
36. Verheijen PM, Lisowski LA, Stoutenbeek P, Hitchcock JF, Bennink GB, Meijboom EJ. 2002. Lactacidosis in the neonate is minimized by prenatal detection of congenital heart disease. Ultrasound Obstet Gynecol 19(6): 552-555.